The affected batches were inadvertently released to the market prior to the completion of the required acceptance activities for embedded particulate matter which may result in leakage. To date, there have been no customer complaints received and there have been no reports of serious injury or death associated with this issue.
Par Pharmaceutical, Inc. has voluntarily recalled one lot of Treprostinil Injection 20mg/20mL (1mg/mL) to the consumer level. The product was recalled due to the potential for the presence of silicone particulates in the product solution.
The recall was initiated due to the potential for presence of glass particulate matter, identified during product inspection.
The recall was initiated due to the potential for presence of glass particulate matter, identified during product inspection.
Injectable products are a type of pharmaceutical formulation designed to be administered directly into the body through a needle....
Ensuring the safety and quality of injectable drugs requires rigorous standards in facility design, equipment selection, and inspection processes....
Sign up for our newsletter to receive the latest findings, updates, and exclusive content delivered directly to your inbox regularly. Don’t miss out on valuable information that can keep you up-to-date and engaged with our ongoing mission!
Sponsored News
Bulk Package
Subscriptions
Customer Support
Worldwide Politics
Sponsored News
Bulk Package
Subscriptions
Customer Support
Worldwide Politics
Sponsored News
Bulk Package
Subscriptions
Customer Support
Worldwide Politics
Sign up for our newsletter to receive the latest findings, updates, and exclusive content delivered directly to your inbox regularly. Don’t miss out on valuable information that can keep you up-to-date and engaged with our ongoing mission!
© 2024 MVI Pharma
